About Harshinipharma
Harshinipharma is a Healthcare company based in India. Research-driven pharmaceutical firm developing and supplying drug intermediates transparently. It operates on a B2B model. Harshinipharma offers products and services including Benzophenone, DMAP, 4-Hydroxy Acetophenone, Epinastine Intermediate, and Bepostatin Intermediate. Its focus areas include Life Sciences, Pharmaceuticals, Research and Development and Drug Synthesis. Its legal entity in India is Harshini Pharmaceuticals Private Limited (U24290TN2022PTC154527).
Company details
Harshini Pharmaceuticals Private Limited is a leading research-driven company in the pharmaceutical sector, focusing on developing high-quality drug intermediates like Benzophenone and DMAP. It operates with transparency and integrity, driven by women entrepreneurs, to exceed international standards. Based in Chennai, India, the company aims to enhance global health through innovative chemical synthesis and reliable production, attracting top talent and building customer trust.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website harshinipharma.com
- Legal Name Harshini Pharmaceuticals Private Limited
- Date of Incorporation 10 Aug, 2022
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹1,000
FY 2024
- Net Loss-₹1.9 Lakh
FY 2024 · -19024% margin
- EBITDA-₹76,042
FY 2024 · -7598% margin
- Employee Count1
Associated legal entities of Harshinipharma
Harshinipharma operates through Harshini Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Harshini Pharmaceuticals Private Limited CIN U24290TN2022PTC154527 | Active | 10 Aug 2022 | Chennai, Tamil Nadu | ₹0.0 Cr | 3 | View details |
Products & Services of Harshinipharma
Harshinipharma offers a comprehensive portfolio of products and services, including Benzophenone, DMAP, 4-Hydroxy Acetophenone, Epinastine Intermediate, and Bepostatin Intermediate.
Key compound used in pharmaceutical synthesis for drug production.
Catalyst in organic reactions for efficient drug manufacturing processes.
Building block for synthesizing pharmaceutical compounds and intermediates.
Component in antihistamine drug production for allergy treatments.
Material for antibiotic synthesis in pharmaceutical applications.
Substance used in drug formulation and research development processes.
Board of directors of Harshini Pharmaceuticals Private Limited (Harshinipharma)
Harshini Pharmaceuticals Private Limited is the primary company behind Harshinipharma. The board of Harshini Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Prakash Rajamani Iyer, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prakash Rajamani Iyer DIN 09696640 | Director | 10 Aug 2022 | 4 yrs 2 mo | Harshini Pharmaceuticals Private Limited |
| Prakash Harshini DIN 09696641 | Director | 10 Aug 2022 | 4 yrs 2 mo | Harshini Pharmaceuticals Private Limited |
| Prakash Ramya DIN 09696953 | Director | 10 Aug 2022 | 4 yrs 2 mo | Harshini Pharmaceuticals Private Limited |
Financials of Harshinipharma
Figures of Harshini Pharmaceuticals Private Limited, the primary company behind Harshinipharma, for FY 2024. Revenue was ₹1,000. Net loss was -₹1.9 Lakh (-19024% margin). EBITDA was -₹76,042 (-7598% margin).
- ₹1,000Revenue · FY 2024
- -₹1.9 LakhNet loss · -19024% margin
- -₹76,042EBITDA · -7598% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Harshini Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Harshinipharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Harshinipharma
Harshinipharma is headquartered in India.
Harshinipharma has 1 employees.
The primary company behind Harshinipharma, Harshini Pharmaceuticals Private Limited, reported revenue of ₹1,000 for FY 2024.
Harshini Pharmaceuticals Private Limited is a leading research-driven company in the pharmaceutical sector, focusing on developing high-quality drug intermediates like Benzophenone and DMAP. It operates with transparency and integrity, driven by women entrepreneurs, to exceed international standards. Based in Chennai, India, the company aims to enhance global health through innovative chemical synthesis and reliable production, attracting top talent and building customer trust.
Harshinipharma offers Benzophenone, DMAP, 4-Hydroxy Acetophenone, Epinastine Intermediate, and 2 more products and services.
Harshinipharma operates through Harshini Pharmaceuticals Private Limited.
The legal entities of Harshinipharma currently have 3 directors, including Prakash Rajamani Iyer, Prakash Harshini, Prakash Ramya.